132 related articles for article (PubMed ID: 33296336)
21. Rapid recovery of a SARS-CoV-2-infected X-linked agammaglobulinemia patient after infusion of COVID-19 convalescent plasma.
Mira E; Yarce OA; Ortega C; Fernández S; Pascual NM; Gómez C; Alvarez MA; Molina IJ; Lama R; Santamaria M
J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2793-2795. PubMed ID: 32652231
[No Abstract] [Full Text] [Related]
22. Treatment of SARS-CoV-2 relapse with remdesivir and neutralizing antibodies cocktail in a patient with X-linked agammaglobulinaemia.
Palomba E; Carrabba M; Zuglian G; Alagna L; Saltini P; Fortina V; Hu C; Bandera A; Fabio G; Gori A; Muscatello A
Int J Infect Dis; 2021 Sep; 110():338-340. PubMed ID: 34332085
[TBL] [Abstract][Full Text] [Related]
23. A child with X-linked agammaglobulinemia and Kawasaki disease: an unusual association.
Sharma D; Guleria S; Suri D; Rawat A; Garg R; Singh S
Rheumatol Int; 2017 Aug; 37(8):1401-1403. PubMed ID: 28365793
[TBL] [Abstract][Full Text] [Related]
24. Common variable immune deficiency and treatment with intravenous immunoglobulin during pregnancy.
Brinker KA; Silk HJ
Ann Allergy Asthma Immunol; 2012 Jun; 108(6):464-5. PubMed ID: 22626605
[No Abstract] [Full Text] [Related]
25. Observations on the use of Bruton's tyrosine kinase inhibitors in SAR-CoV-2 and cancer.
Benner B; Carson WE
J Hematol Oncol; 2021 Jan; 14(1):15. PubMed ID: 33441177
[TBL] [Abstract][Full Text] [Related]
26. Congenital nephrotic syndrome and agammaglobulinemia: a therapeutic dilemma.
Payne KM; Nelson MR; Petersen MM
Ann Allergy Asthma Immunol; 2013 Aug; 111(2):142-3. PubMed ID: 23886236
[No Abstract] [Full Text] [Related]
27. A Patient with X-Linked Agammaglobulinemia and COVID-19 Infection Treated with Remdesivir and Convalescent Plasma.
Iaboni A; Wong N; Betschel SD
J Clin Immunol; 2021 Jul; 41(5):923-925. PubMed ID: 33547548
[No Abstract] [Full Text] [Related]
28. Pneumocystis jiroveci pneumonia as an atypical presentation of X-linked agammaglobulinemia.
Kanegane H; Nakano T; Shimono Y; Zhao M; Miyawaki T
Int J Hematol; 2009 Jun; 89(5):716-7. PubMed ID: 19399581
[No Abstract] [Full Text] [Related]
29. Membranous glomerulopathy in an adult patient with X-linked agammaglobulinemia receiving intravenous gammaglobulin.
Endo LM; Giannobile JV; Dobbs AK; Foote JB; Szymanska E; Warnock DG; Cook WJ; Conley ME; Schroeder HW
J Investig Allergol Clin Immunol; 2011; 21(5):405-9. PubMed ID: 21905506
[TBL] [Abstract][Full Text] [Related]
30. A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia.
Quinti I; Lougaris V; Milito C; Cinetto F; Pecoraro A; Mezzaroma I; Mastroianni CM; Turriziani O; Bondioni MP; Filippini M; Soresina A; Spadaro G; Agostini C; Carsetti R; Plebani A
J Allergy Clin Immunol; 2020 Jul; 146(1):211-213.e4. PubMed ID: 32333914
[No Abstract] [Full Text] [Related]
31. Clinical and molecular analysis of 49 patients with X-linked agammaglobulinemia from a single center in Argentina.
Basile N; Danielian S; Oleastro M; Rosenzweig S; Prieto E; Rossi J; Roy A; Zelazko M
J Clin Immunol; 2009 Jan; 29(1):123-9. PubMed ID: 18677443
[TBL] [Abstract][Full Text] [Related]
32. Transient myelodysplastic syndrome in X-linked agammaglobulinemia with a novel Btk mutation.
Narula G; Currimbhoy Z
Pediatr Blood Cancer; 2008 Dec; 51(6):826-8. PubMed ID: 18726917
[TBL] [Abstract][Full Text] [Related]
33. Iris atrophy in a patient with X-linked agammaglobulinemia.
Reisli I; Artac H; van der Burg M; Ozturk BT
Can J Ophthalmol; 2007 Dec; 42(6):882-3. PubMed ID: 18059520
[No Abstract] [Full Text] [Related]
34. [Oligoarthritis in the framework of a Bruton-type agammaglobulinemia. Presentation of an atypical case in a 2-year-old child].
Albert J; Ott H
Rev Rhum Mal Osteoartic; 1983 Feb; 50(2):155-8. PubMed ID: 6857129
[No Abstract] [Full Text] [Related]
35. Genomic organization and structure of Bruton agammaglobulinemia tyrosine kinase: localization of mutations associated with varied clinical presentations and course in X chromosome-linked agammaglobulinemia.
Ohta Y; Haire RN; Litman RT; Fu SM; Nelson RP; Kratz J; Kornfeld SJ; de la Morena M; Good RA; Litman GW
Proc Natl Acad Sci U S A; 1994 Sep; 91(19):9062-6. PubMed ID: 8090769
[TBL] [Abstract][Full Text] [Related]
36. [A case of epilepsy with agammaglobulinemia improved by intravenous immunoglobulin therapy].
Kohno C; Kitou H
No To Hattatsu; 2000 Jan; 32(1):56-61. PubMed ID: 10655753
[TBL] [Abstract][Full Text] [Related]
37. Metastatic colorectal cancer and severe hypocalcemia following irinotecan administration in a patient with X-linked agammaglobulinemia: a case report.
Li M; Chen W; Sun X; Wang Z; Zou X; Wei H; Wang Z; Chen W
BMC Med Genet; 2019 Sep; 20(1):157. PubMed ID: 31510946
[TBL] [Abstract][Full Text] [Related]
38. SARS-CoV-2 infection in a X-linked agammaglobulinemia adolescent: An immunological approach to treatment.
Stracuzzi M; Vanetti C; Clerici M; Zuccotti GV; Trabattoni D; Giacomet V
Pediatr Allergy Immunol; 2023 Mar; 34(3):e13921. PubMed ID: 36974650
[No Abstract] [Full Text] [Related]
39. Relevance of the Bruton Tyrosine Kinase as a Target for COVID-19 Therapy.
Rada M; Qusairy Z; Massip-Salcedo M; Macip S
Mol Cancer Res; 2021 Apr; 19(4):549-554. PubMed ID: 33328281
[TBL] [Abstract][Full Text] [Related]
40. A 44-Year-Old Hispanic Man with Loss of Taste and Bilateral Facial Weakness Diagnosed with Guillain-Barré Syndrome and Bell's Palsy Associated with SARS-CoV-2 Infection Treated with Intravenous Immunoglobulin.
Khaja M; Gomez GPR; Santana Y; Hernandez N; Haider A; Lara JLP; Elkin R
Am J Case Rep; 2020 Oct; 21():e927956. PubMed ID: 33128540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
